Starbucks Corporation (NASDAQ: SBUX) beats Q4-FY2026 EPS consensus of $0.72 per share — quarterly report October 29, 2026 after market close (confirmed by Starbucks Investor Relations or Bloomberg by October 30, 2026, 10:00 AM ET)
Pending
✦ AI-generated prediction
Published on 22. October 2026
·
Predicted for 29. October 2026
·
Based on: Historical Cycle
Starbucks is in a robust turnaround under CEO Brian Niccol: Q3 FY2026 beat the Non-GAAP EPS consensus by 29% ($0.85 vs. ~$0.66 expected) with four consecutive quarters of positive comparable store sales growth (+7.9% in Q3). Cost savings of >$2B implemented ('Back to Starbucks' strategy). Q4 consensus of $0.72 accounts for seasonal slowdown but should again be exceeded given operational momentum — CNBC raised its price target after Q2 beat-and-raise report. Main risk: Q4 revenue expected -3.3% YoY; turnaround not yet fully complete. Category: beverages (coffee chain).
Data basis for this prediction
- SEC Form 8-K Starbucks Q3 FY2026: Non-GAAP EPS 0,85 USD (+29% Beat), SSS +7,9% (29.07.2026)
- MarketBeat / Benzinga: SBUX Q4-FY2026 Konsens-EPS 0,71–0,72 USD, Bericht 29.10.2026 nach Börsenschluss
- 247WallSt 05.08.2026: 'Brian Niccol's Turnaround Is Working'; Niccol >2 Mrd. USD Kostensenkungen
- CNBC 28.04.2026: 'We're raising our price target on Starbucks after a robust beat-and-raise quarter'
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
🍾 Beverages
✦ AI
Rémy Cointreau entered FY2026/27 with +1.3% organic growth in Q1 (April–June 2026, €223.2m), led by the Cognac division at +7.7% organic — the strongest quarterly rise in four quarters. Management confirmed mid-2026 a 'return to sustainable organic growth, with momentum expected to strengthen progressively throughout the year.' For H1 organic growth above +2.0%, Q2 (July–September 2026) needs to deliver ~+2.7% organic — plausible given Cognac momentum, favourable base effects (FY2026 full-year −18.0% organic), and typically strong summer trading for premium spirits, but not yet certain. No prediction market or market anchor available; calibrated from Q1 momentum and company guidance.
🍾 Beverages
Hit
✦ AI
Pernod Ricard publishes its Q1 FY2027 sales update on October 15, 2026 at 7:30am CEST. The company itself explicitly flagged Q1 FY27 as the weakest phase of the season: lingering US inventory destocking and structural China adjustments will weigh on results. Q1 FY26 came in at −7.6% organic (full year FY26: −3.9%). No Polymarket contract for this event; the company's own management guidance, the weak macro environment (US September NFP: +29,000 vs. +90,000 consensus), and the share price near a multi-year low (EUR 59.18) all reflect continued demand weakness in the premium spirits segment. Another quarter of negative organic growth is the base case.
🍾 Beverages
Hit
✦ AI
Analyst consensus is USD 2.57 billion (+3.6% YoY); the threshold of 2.55 billion is 0.8% below that. Constellation Brands has beaten consensus in five of the last six quarters, driven by its beer segment (Corona, Modelo, Pacifico) with sustained US import beer market share. Q2-FY2026 reported USD 2.48 billion; implied growth of ~2.8% is below historical trend. No dedicated Polymarket market; calibrated from historical beat rate (~83%) and adjusted for macro headwinds (weak US consumer per Sept jobs: only 29k vs. 84k forecast). No conflicting open predictions.